Latest oppositions filed by Biogaran

This table presents recent patent oppositions filed by Biogaran against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3345604Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH. LUNDBECK A/SMar 6, 2024
EP3578175Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA INC.Apr 20, 2023
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS AGJan 13, 2023
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY, INC.Jan 14, 2022
EP2234617Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA NVDec 23, 2021
EP3395338Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 31, 2020
EP3260117Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 17, 2020
EP3395339Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 17, 2020
EP3395340Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 17, 2020